Person Prof Mark Rosenthal National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects Participant in A 2:1 Randomised Phase II Study of NivolUmab and Temozolomide vs Temozolomide in Methylated newly diagnosed Elderly Glioblastoma (NUTMEG) (funded by National Health and Medical Research Council) Participant in Development of a novel biosensor using magnetically amplified luminescence for the early detection of cancer (funded by National Health and Medical Research Council) Participant in Epigenetic predictors of outcome in malignant glioma (funded by National Health and Medical Research Council) Participant in Radiotherapy vs chemotherapy for low-grade gliomas stratified for genetic 1p loss: efficacy and quality of life benefits (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects Participant in A 2:1 Randomised Phase II Study of NivolUmab and Temozolomide vs Temozolomide in Methylated newly diagnosed Elderly Glioblastoma (NUTMEG) (funded by National Health and Medical Research Council) Participant in Development of a novel biosensor using magnetically amplified luminescence for the early detection of cancer (funded by National Health and Medical Research Council) Participant in Epigenetic predictors of outcome in malignant glioma (funded by National Health and Medical Research Council) Participant in Radiotherapy vs chemotherapy for low-grade gliomas stratified for genetic 1p loss: efficacy and quality of life benefits (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover
